TITLE

Branders Beware

AUTHOR(S)
Stephan, S. Kent
PUB. DATE
February 2001
SOURCE
Pharmaceutical Executive;Feb2001, Vol. 21 Issue 2, p102
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Focuses on the prescribing behavior of physicians. Perceptions of physicians on the details of a brand; Factors affecting the marketing of drugs; Impact of advertisements on the perceptions of physicians and patients regarding a certain drug; Other approaches used by pharmaceutical companies in marketing their products.
ACCESSION #
4113020

 

Related Articles

  • Specificity of Pharmaceutical Marketing and requirements for prescription drugs' promotion in Bosnia and Herzegovina. Lekic, L.; Mulabegovic, N.; Tihi, B. // Folia Medica Facultatis Medicinae Universitatis Saraeviensis;2010, Vol. 45 Issue 1, p29 

    Pharmaceutical industry is one of the most regulated industries in the world. However, it has seen major changes in the recent years that set new demands on customers, providers and manufacturers. Customers now demand from pharmacology industry the same choice and convenience they find in other...

  • On TRACK: Intended and Unintended Consequences of Direct-to-Consumer Drug Marketing. Stange, Kurt C. // Annals of Family Medicine;Mar/Apr2007, Vol. 5 Issue 2, p175 

    The article discusses the issue regarding the intended and unintended consequences of direct-to-consumer (DTC) drug marketing. According to some medical experts, DTC advertising is considered as more effective than doctors at motivating patients since it raises issues that were difficult to...

  • On TRACK: Intended and Unintended Consequences of Direct-to-Consumer Drug Marketing. Stange, Kurt C. // Annals of Family Medicine;Mar/Apr2007, Vol. 5 Issue 2, p175 

    The article discusses the issue regarding the intended and unintended consequences of direct-to-consumer (DTC) drug marketing. According to some medical experts, DTC advertising is considered as more effective than doctors at motivating patients since it raises issues that were difficult to...

  • Advertising oversell?  // Nature Reviews Drug Discovery;Oct2008, Vol. 7 Issue 10, p787 

    A recent study of direct-to-consumer drug advertising suggests that its impact on prescribing rates may be more limited than usually assumed. Given the considerable costs involved, as well as the contribution that controversy over such advertising may have made to negative perceptions of the...

  • Promotion Might Enable Addiction. Meyer, Natasha T. // Pharmaceutical Executive;Aug2005, Vol. 25 Issue 8, p24 

    Reports on findings of a study by the National Center on Addiction and Substance Abuse at Columbia University showing the increasing cases of prescription drug abuse in the United States. Relation between aggressive marketing of controlled drugs and over-prescription; Call for an end to...

  • Study confirms DTC Rxing link.  // Medical Marketing & Media;Apr2002, Vol. 37 Issue 4, p26 

    Reports on the relationship between direct to consumer advertising expenditures with prescription of drugs by the physician in the U.S. Period of the study; Complexity of the advertising-prescribing relationship; Role of Woodie M. Zachary III in the study.

  • Pharmaceutical Ads Tune in to Consumers. Xenakis, Alan; Lutwick, Larry I. // Cortlandt Forum;Sep98, Vol. 11 Issue 9, p70 

    Reports on the increase of prescription drug advertisements compared to regular consumer products. Reason for the increase; Response of some writers on the trend according to the May 23, 1998 issue `Lancet.'

  • 2002 Rx MARKET: A LOOK IN THE REARVIEW MIRROR. Gebhart, Fred // Drug Topics;3/17/2003, Vol. 147 Issue 6, p37 

    Provides an overview on the prescription drug market in the United States in 2002. Percentage decline in prescription orders; Increase in prescription refills; Popular prescription drugs; Growth in generic drug sales.

  • Prescribing update. Saunders, Carol S.; Krohn, Talia S. // Patient Care;8/30/2000, Vol. 34 Issue 16, p9 

    Presents news updates pertaining to drug prescribing in the United States as of August 30, 2000. Novo Nordisk AS' insulin aspart injection NovoLog; Immunex Corp.'s Enbrel etanercept; Briston-Myers Squibb Co.'s Pravachol pravastatin.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics